SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-016285
Filing Date
2020-02-11
Accepted
2020-02-11 16:27:57
Documents
3
Period of Report
2020-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207374-1_8k.htm 8-K 29895
2 EXHIBIT 99.1 tm207374d1_ex99-1.htm EX-99.1 10175
3 GRAPHIC tm207374d1_ex99-1img01.jpg GRAPHIC 2454
  Complete submission text file 0001104659-20-016285.txt   44967
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 20596975
SIC: 2836 Biological Products, (No Diagnostic Substances)